Maria Teresa Pirrotta

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura

Francesco Zaja, Marta Lisa Battista, Maria Teresa Pirrotta et al. · Haematologica · 2008 · 101 citations · Full text

Immunology, Pharmacotherapy, Immunotherapy +18

Liposomal daunorubicin <i>versus</i> standard daunorubicin: long term follow‐up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia

Roberto Latagliata, Massimo Breccia, Paola Fazi et al. · British Journal of Haematology · 2008 · 54 citations · Full text

Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an italian multicentric phase II study.

Pier Paolo Piccaluga, Michele Malagola, Michela Rondoni et al. · Haematologica · 2007 · 18 citations · Full text

Unusual Discordant Responses in Two Multiple Myeloma Patients during Bortezomib Treatment

Maria Teresa Pirrotta, Alessandro Gozzetti, Alfonso Cerase et al. · Onkologie · 2008 · 16 citations

Multiple Myeloma Involving the Cavernous Sinus: A Report of 3 Cases and Response to Bortezomib

Alessandro Gozzetti, Alfonso Cerase, Annachiara Tarantino et al. · Clinical Lymphoma & Myeloma · 2007 · 15 citations

Multiple Myeloma, Cavernous Sinus